Isonipecotic Acid CAS 498-94-2 Factory High Purity

Short Description:

Chemical Name: Isonipecotic Acid 

CAS: 498-94-2

Appearance: White Crystalline Powder

Assay: 98.0%~102.0%

High Quality, Commercial Production

Inquiry: alvin@ruifuchem.com


Product Detail

Related Products

Product Tags

Description:

Chemical Properties:

Chemical Name Isonipecotic Acid
Synonyms 4-Piperidinecarboxylic Acid; H-DL-Inp-OH
CAS Number 498-94-2
CAT Number RF-PI285
Stock Status In Stock, Production Scale Up to Tons
Molecular Formula C6H11NO2
Molecular Weight 129.16
Solubility Solubility in Water: Very Faint Turbidity
Shipping Condition Shipped Under Ambient Temperature
Brand Ruifu Chemical

Specifications:

Item Specifications
Appearance White Crystalline Powder
Melting Point 300℃ min
Identification IR, NMR
Assay 98.0%~102.0%
Loss on Drying ≤1.0%
Residue on Ignition ≤1.0%
Bacterial Emdotoxins ≤5IU/mg
Test Standard Enterprise Standard; Chinese Pharmacopoeia (CP)
Usage Pharmaceutical Intermediates

Package & Storage:

Package: Bottle, Aluminium foil bag, Cardboard Drum, 25kg/Drum, or according to customer's requirement.

Storage Condition: Store in sealed containers at cool and dry place; Protect from light, moisture and pest infestation.

Advantages:

1

FAQ:

Application:

Shanghai Ruifu Chemical Co., Ltd. is the leading manufacturer and supplier of Isonipecotic Acid, 4-Piperidinecarboxylic Acid (CAS: 498-94-2) with high quality, widely used in organic synthesis, synthesis of pharmaceutical intermediates and Active Pharmaceutical Ingredient (API) synthesis.

Isonipecotic Acid, 4-Piperidinecarboxylic Acid (CAS: 498-94-2) is an important reactant for the synthesis of alkyl piperidine and piperazine hydroxamic acids as HDAC inhibitors. It is also used in the synthesis of antibiotic nitroxoline derivatives for cathepsin B inhibition.

Application
Reactant for synthesis of:
Antibiotic nitroxoline derivatives for cathepsin B inhibition
Sphingosine-1-phosphate receptor agonists
RhoA inhibitors for cardiovascular disease therapy
Alkyl piperidine and piperazine hydroxamic acids as HDAC inhibitors
CHK1 inhibitors
IKK2 inhibitors for investigations into rheumatoid arthritis treatment

  • Write your message here and send it to us